Black Diamond Therapeutics shows promise with BDTX-1535 for NSCLC treatment. Click here to find out why I rate BDTX stock a ...

Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

Jay Ferro is the Chief Information, Technology and Product Officer at Clario, he has over 25 years of experience leading ...

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, Sunday announced that it has entered into an exclusive global ...

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced that it has entered into exclusive license ...

This overall agreement is a significant development for IDEAYA Biosciences, positioning the company to advance its precision ...

To maximize its cash runway while the Board conducts its review of strategic alternatives, Viracta has elected to close its ongoing pivotal Phase 2 clinical trial of Nana-val in relapsed/refractory ...

The Abu Dhabi Stem Cells Center (ADSCC) has successfully performed four testicular tissue cryopreservation (TTC) procedures ...

Gene Solutions' proprietary research and CAP-accredited laboratories in Singapore and Vietnam set it apart from other players ...

ERAS), a clinical-stage precision oncology company, recently provided updates on its R&D advancements targeting RAS/MAPK pathway-driven cancers. In October 2024, the company presented promising Phase ...